Advertisement
Australia markets open in 17 minutes
  • ALL ORDS

    7,897.50
    +48.10 (+0.61%)
     
  • AUD/USD

    0.6612
    -0.0001 (-0.01%)
     
  • ASX 200

    7,629.00
    +42.00 (+0.55%)
     
  • OIL

    78.52
    +0.41 (+0.52%)
     
  • GOLD

    2,307.90
    -0.70 (-0.03%)
     
  • Bitcoin AUD

    96,981.41
    +279.41 (+0.29%)
     
  • CMC Crypto 200

    1,333.76
    +56.78 (+4.45%)
     

Zynex Sets First Quarter 2024 Earnings Call

ENGLEWOOD, Colo., April 18, 2024 /PRNewswire/ -- Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, rehabilitation, and patient monitoring, will hold a conference call on Tuesday, April 30, 2024 at 4:15 PM Eastern Time to discuss its financial results for the first quarter ended March 31, 2024.  Financial results will be issued in a press release prior to the call.

Zynex
Zynex

Zynex management will host the conference call, followed by a question and answer session.

Date: Tuesday, April 30, 2024
Time: 4:15 PM Eastern Time (2:15 PM Mountain Time)
U.S. & Canada dial-in number: 800-836-8184
International number: 646-357-8785
Webcast: 1Q 2024 Webcast Link

ADVERTISEMENT

The Company will also provide a link at https://zynexmed.investorroom.com/ for those who wish to stream the call via webcast. Please call the conference telephone number 5-10 minutes prior to the start time.

About Zynex, Inc.

Zynex, founded in 1996, develops, manufactures, markets, and sells medical devices used for pain management and rehabilitation as well as non-invasive fluid, sepsis, and laser-based pulse oximetry monitoring systems for use in hospitals. For additional information, please visit: www.zynex.com.

Investor Relations Contact:
Quinn Callanan, CFA or Brian Prenoveau, CFA
MZ Group – MZ North America
ZYXI@mzgroup.us
+949 694 9594

Cision
Cision

View original content to download multimedia:https://www.prnewswire.com/news-releases/zynex-sets-first-quarter-2024-earnings-call-302120512.html

SOURCE Zynex